The Valley Desk

ArticleBioanalysisPublished

2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)

15 of 63 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Bioanalysis
Published
Subject terms
Humans; Vaccines; Genomics; High-Throughput Nucleotide Sequencing; Genetic Therapy; Cell- and Tissue-Based Therapy; Biomarkers; Clinical Relevance; Gene therapy; Vaccine; Immunogenicity; Cell therapy
PubMed ID
39862111
PubMed Central ID
PMC11863570
Added to directory
Source checked

Report a correction or request removal